Özge Atılgan Karakulak and Selin Sinem Erciyas will Speak at the Pharma Biotech Patent Litigation Europe Summit

Özge Atılgan Karakulak and Selin Sinem Erciyas, partners in our Life Sciences and Patents and Utility Models practices, will speak at the Pharma Biotech Patent Litigation Europe Summit in Amsterdam, which will take place on January 21–22, 2026.

They will speak in the following sessions: Özge Atılgan Karakulak in “Competition Law Review from the Life Sciences Sector: A Review of Recent Court Decisions”, and Selin Sinem Erciyas in “Preliminary Injunction Review for the Life Sciences Sector.”

The summit explores the evolving landscape of cross-border patent litigation strategies, highlighting the latest UPC developments and landmark rulings. Sessions will cover SPCs, PTEs, Bolar exemptions, and ongoing regulatory reforms across Europe and the U.S. Sector-focused discussions on MedTech, small molecule, and large molecule litigation will provide tailored insights, while panels on AI patentability, second medical use claims, skinny labels, and competition law in pharma address today’s most pressing challenges in the IP and life sciences sectors.

For more information, click here.